REQUEST A DEMO
Total
USD $0.00
Search more companies

Shandong Wohua Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shandong Wohua Pharmaceutical Co., Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shandong Wohua Pharmaceutical Co., Ltd. is a publicly listed company located in Weifang, China. With a history dating back to the Qing Dynasty, it is a century-old producer of traditional Chinese medicine. The company specializes in the field of cardiovascular and cerebrovascular medicine and focuses on the production of natural plant-based remedies in this segment. Their product range includes over 100 varieties, such as tablets, capsules, oral liquids, pills, powders, and ointments. Some of their main products include Xinkeshu tablets, Amber Stone Granules, Yuandu Hanbi Liquid, and Orange Red Pear Paste. Shandong Wohua Pharmaceutical has established long-term collaborations with research institutions such as Beijing University of Chinese Medicine and the Institute of Materia Medica of the Chinese Academy of Medical Sciences. Together, they have developed over 10 new drug varieties, applied for 12 national invention patents, and obtained 6 proprietary technologies. The company has been recognized as a national high-tech enterprise and has received honors such as "Quality Star Enterprise" and "Trusted Pharmaceutical Factory" from provincial and municipal food and drug supervision authorities. It has also been rated as a "Credit Enterprise" and "AAA Credit Enterprise" by the financial system in Weifang City. Additionally, Shandong Wohua Pharmaceutical has been awarded the title of "Contract-Abiding and Credit-Reliable Unit" by the Shandong Provincial Administration for Industry and Commerce for multiple consecutive years.

Headquarters
No. 3517, Liyuan Street, High-tech Industrial Development Zone, Weifang City, Shandong Province
Weifang; Shandong; Postal Code: 261205

Contact Details: Purchase the Shandong Wohua Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.wohua.cn

Basic Information
Total Employees:
Purchase the Shandong Wohua Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shandong Wohua Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shandong Wohua Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shandong Wohua Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
February 09, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
50.27%
Purchase this report to view the information.
1.74%
Purchase this report to view the information.
0.65%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.34%
Subsidiaries
Beijing Wohua Yuyou Brand Culture Co., Ltd.
100%
Donggang Kangming Industrial Co., Ltd.
100%
Shandong Wohua Chinese Medicine Research Institute Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shandong Wohua Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-19.5%
Total operating revenue
-19.5%
Operating profit (EBIT)
-44.6%
Net Profit (Loss) for the Period
-56.63%
Total assets
-12%
Total equity
-14.88%
Operating Profit Margin (ROS)
-2.08%
Net Profit Margin
-2.99%
Return on Equity (ROE)
-2.73%
Quick Ratio
-0.27%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?